Second University Department of Pediatrics, P. and A. Kyriakou Children's Hospital, National and Kapodistrian University of Athens School of Medicine, Athens, Greece.
J Pediatr. 2012 Oct;161(4):632-8. doi: 10.1016/j.jpeds.2012.04.007. Epub 2012 May 24.
To evaluate the effect of age upon QuantiFERON-TB Gold-In-Tube (QFT-IT) assay outcome among children examined for latent tuberculosis infection (LTBI).
A cross-sectional study was conducted among 761 children (mean age ± SD: 7.84 ± 4.68 years) evaluated for LTBI. Participants were examined with both tuberculin skin test and QFT-IT (Cellestis, Australia) and categorized into 4 age groups. Multivariate logistic and linear regressions were used to evaluate the association between selected demographic and patient characteristics upon the qualitative and quantitative QFT-IT outcomes. Agreement between the tuberculin skin test and QFT-IT within groups was evaluated with the κ statistic.
QFT-IT indeterminate results occurred more frequently among young children (8.1%; P < .0001) and children (2.7%; P = .025) than adolescents (0.7%). Among QFT-IT positive patients, infants had higher mean (± SD) interferon-gamma (IFNγ) concentration than adolescents. QFT-IT positive (vs negative) outcome was associated with origin from a high tuberculosis endemicity setting (AOR = 4.54; 95% CI, 3.22-6.25) and lack of previous Bacille Calmette Guerin immunization (AOR = 2.70; 95% CI, 1.89-3.85), but not patient age (AOR = 0.96; 95% CI, 0.92-0.99). However, among QFT-IT positive patients, the IFNγ concentration was inversely associated with patient age (P = .009) and positively with mitogen response (P = .0002). Agreement between tests was not significantly different between younger and older children in the different risk groups.
Qualitative QFT-IT assay results are not affected by patient age. However, indeterminate results occur more frequently among younger children. Among patients with LTBI the quantitative QFT-IT result (ie, IFNγ) is inversely associated with patient age.
评估年龄对 QuantiFERON-TB Gold-In-Tube(QFT-IT)检测结果在潜伏性结核感染(LTBI)检测中的影响。
本研究为横断面研究,共纳入 761 名(平均年龄±标准差:7.84±4.68 岁)LTBI 检测患儿。所有患儿均接受结核菌素皮肤试验和 QFT-IT(Cellestis,澳大利亚)检测,并分为 4 个年龄组。采用多元逻辑回归和线性回归评估所选人口统计学和患者特征与 QFT-IT 定性和定量结果之间的关系。采用κ统计量评估组内结核菌素皮肤试验和 QFT-IT 之间的一致性。
QFT-IT 不确定结果在幼儿(8.1%;P<0.0001)和儿童(2.7%;P=0.025)中较青少年(0.7%)更为常见。QFT-IT 阳性患者中,婴儿的干扰素-γ(IFNγ)浓度高于青少年。与 QFT-IT 阴性相比,QFT-IT 阳性(AOR=4.54;95%CI,3.22-6.25)与来自高结核流行地区(AOR=4.54;95%CI,3.22-6.25)和缺乏卡介苗免疫(AOR=2.70;95%CI,1.89-3.85)相关,与患者年龄无关(AOR=0.96;95%CI,0.92-0.99)。然而,在 QFT-IT 阳性患者中,IFNγ浓度与患者年龄呈负相关(P=0.009),与有丝分裂原反应呈正相关(P=0.0002)。在不同风险组中,年幼和年长患儿之间的检测一致性并无显著差异。
QFT-IT 检测结果的定性不受患者年龄影响。然而,年幼患儿的不确定结果更为常见。在 LTBI 患者中,QFT-IT 定量结果(即 IFNγ)与患者年龄呈负相关。